Idiopathic cystitis in domestic cats-beyond the lower urinary tract

Journal of Veterinary Internal Medicine

Volumn 25, Issue 4, 2011, Pages 784-796

  Buffington, C A Tony ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Comorbidity; Developmental biology; Etiology; Phenotype; Syndrome

Indexed keywords

ANIMAL; ANIMAL DISEASE; CAT; CAT DISEASE; COMPARATIVE STUDY; CYSTITIS; HUMAN; PATHOPHYSIOLOGY; REVIEW;

ANIMALS; CAT DISEASES; CATS; CYSTITIS; HUMANS;

FELIS CATUS;

EID: 79960554451     PISSN: 08916640     EISSN: 19391676     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2011.0732.x     Document Type: Review

References (195)

1. Westropp J, Buffington CAT. Lower urinary tract disorders in cats. In: Ettinger SJ, Feldman EC, eds. Textbook of Veterinary Internal Medicine, 7th ed. St. Louis, MO: Elsevier-Saunders; 2010:2069-2086.
2. Osborne CA, Kruger JM, Lulich JP. Feline lower urinary tract disorders. Definition of terms and concepts. Vet Clin North Am Small Anim Pract 1996;26:169-179.
3. Baranowski AP, Abrams P, Berger RE, et al. Urogenital pain-time to accept a new approach to phenotyping and, as a consequence, management. Eur Urol 2008;53:33-36.
4. Hanno P, Lin A, Nordling J, et al. Bladder pain syndrome committee of the international consultation on incontinence. Neurourol Urodyn 2010;29:191-198.
5. Buffington CA, Chew DJ, DiBartola SP. Interstitial cystitis in cats. Vet Clin North Am Small Anim Pract 1996;26:317-326.
6. Osborne CA, Kruger JM, Lulich JP, et al. Feline urologic syndrome, feline lower urinary tract disease, feline interstitial cystitis: What's in a name? J Am Vet Med Assoc 1999;214:1470-1480.
7. Hanno PM. Re-imagining interstitial cystitis. Urol Clin North Am 2008;35:91-99.
8. Feinstein AR. The Blame-X syndrome: Problems and lessons in nosology, spectrum, and etiology. J Clin Epidemiol 2001;54:433-439.
9. Osbaldiston GW, Taussig RA. Clinical report on 46 cases of feline urological syndrome. Vet Med/Small Anim Clin 1970;65:461-468.
10. Osborne CA, Johnston GR, Polzin DJ, et al. Redefinition of the feline urologic syndrome: Feline lower urinary tract disease with heterogeneous causes. Vet Clin North Am Small Anim Pract 1984;14:409-438.
11. Buffington CAT, Chew DJ, Woodworth BE. Feline interstitial cystitis. J Am Vet Med Assoc 1999;215:682-687.
12. Schur EA, Afari N, Furberg H, et al. Feeling bad in more ways than one: Comorbidity patterns of medically unexplained and psychiatric conditions. J Gen Intern Med 2007;22:818-821.
13. Ablin K, Clauw DJ. From fibrositis to functional somatic syndromes to a bell-shaped curve of pain and sensory sensitivity: Evolution of a clinical construct. Rheum Dis Clin North Am 2009;35:233-251.
14. Yunus MB. Central sensitivity syndromes: A new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness. Semin Arthritis Rheum 2008;37:339-352.
15. Buffington CAT, Westropp JL, Chew DJ, et al. Clinical evaluation of multimodal environmental modification (MEMO) in the management of cats with idiopathic cystitis. J Feline Med Surg 2006;8:261-268.
16. Buffington CAT, Westropp JL, Chew DJ, et al. A case-control study of indoor-housed cats with lower urinary tract signs. J Am Vet Med Assoc 2006;228:722-725.
17. Westropp JL, Kass PH, Buffington CAT. Evaluation of the effects of stress in cats with idiopathic cystitis. Am J Vet Res 2006;67:731-736.
18. Stella JL, Lord LK, Buffington CAT. Sickness behaviors in response to unusual external events in healthy cats and cats with feline interstitial cystitis. J Am Vet Med Assoc 2011;238:67-73.
19. Buffington CAT. Bladder pain syndrome/interstitial cystitis. In: Baranowski AP, Abrams P, Fall M, eds. Urogenital Pain in Clinical Practice. New York: Informa Healthcare, USA; 2008:169-183.
20. Buffington CAT. Comorbidity of interstitial cystitis with other unexplained clinical conditions. J Urol 2004;172:1242-1248.
21. Wu EQ, Birnbaum H, Kang YJ, et al. A retrospective claims database analysis to assess patterns of interstitial cystitis diagnosis. Curr Med Res Opin 2006;22:495-500.
22. Warren JW, Howard FM, Cross RK, et al. Antecedent nonbladder syndromes in case-control study of interstitial cystitis/painful bladder syndrome. Urology 2009;73:52-57.
23. Weissman MM, Gross R, Fyer A, et al. Interstitial cystitis and panic disorder: A potential genetic syndrome. Arch Gen Psychiatry 2004;I61:273-279.
24. Dimitrakov JD. A case of familial clustering of interstitial cystitis and chronic pelvic pain syndrome. Urology 2001;58:281vi-viii.
25. Westropp JL, Welk KA, Buffington CAT. Small adrenal glands in cats with feline interstitial cystitis. J Urol 2003;170:2494-2497.
26. Buffington CAT. Developmental influences on medically unexplained symptoms. Psychother Psychosom 2009;78:139-144.
27. Clasper M. A case of interstitial cystitis and Hunner's ulcer in a domestic shorthaired cat. N Z Vet J 1990;38:158-160.
28. Hanno PM. Painful bladder syndrome/interstitial cystitis and related diseases. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, eds. Campbell-Walsh Urology, 9th ed. Philadelphia, PA: W.B. Saunders Company; 2007:330-370.
29. Fowler CJ, Griffiths D, de Groat WC. The neural control of micturition. Nat Rev Neurosci 2008;9:453-466.
30. Birder LA, Wolf-Johnston AS, Chib MK, et al. Beyond neurons: Involvement of urothelial and glial cells in bladder function. Neurourol Urodyn 2010;29:88-96.
31. Kanai A, Andersson KE. Bladder afferent signaling: Recent findings. J Urol 2010;183:1288-1295.
32. Holstege G. Micturition and the soul. J Comp Neurol 2005;493:15-20.
33. Powell-Boone T, Ness TJ, Cannon R, et al. Menstrual cycle affects bladder pain sensation in subjects with interstitial cystitis. J Urol 2005;174:1832-1836.
34. Rajasekaran M, Stein P, Parsons CL. Toxic factors in human urine that injure urothelium. Int J Urol 2006;13:409-414.
35. Buffington CA, Blaisdell JL, Binns SP Jr, et al. Decreased urine glycosaminoglycan excretion in cats with interstitial cystitis. J Urol 1996;155:1801-1804.
36. Parsons CL, Schmidt JD, Pollen JJ. Successful treatment of interstitial cystitis with sodium pentosanpolysulfate. J Urol 1983;130:51-53.
37. Kruger JM, Osborne CA. The role of uropathogens in feline lower urinary tract disease. Clinical implications. Vet Clin North Am Small Anim Pract 1993;23:101-123.
38. Keay SK, Warren JW. Is interstitial cystitis an infectious disease? Int J Antimicrob Agents 2002;19:480-483.
39. Argade SP, Vanichsarn C, Chenoweth M, et al. Abnormal glycosylation of Tamm-Horsfall protein in patients with interstitial cystitis. BJU Int 2009;103:1085-1089.
40. Keay S. Cell signaling in interstitial cystitis/painful bladder syndrome. Cell Signal 2008;20:2174-2179.
41. Erickson DR, Tomaszewski JE, Kunselman AR, et al. Urine markers do not predict biopsy findings or presence of bladder ulcers in interstitial cystitis/painful bladder syndrome. J Urol 2008;179:1850-1856.
42. Goo YA, Tsai YS, Liu AY, et al. Urinary proteomics evaluation in interstitial cystitis/painful bladder syndrome: A pilot study. Int Braz J Urol 2010;36:464-478; discussion 478-469, 479.
43. Raffi HS, Bates JM Jr, Laszik Z, et al. Tamm-Horsfall protein acts as a general host-defense factor against bacterial cystitis. Am J Nephrol 2005;25:570-578.
44. Hunner GL. A rare type of bladder ulcer in women: Report of cases. Boston Med Soc J 1915;172:247-292.
45. Fabricant CG. The feline urologic syndrome induced by infection with a cell-associated herpesvirus. Vet Clin North Am Small Anim Pract 1984;14:493-502.
46. Kruger JM, Osborne CA, Lulich JP. Changing paradigms of feline idiopathic cystitis. Vet Clin North Am Small Anim Pract 2009;39:15-40.
47. Al-Hadithi HN, Williams H, Hart CA, et al. Absence of bacterial and viral DNA in bladder biopsies from patients with interstitial cystitis/chronic pelvic pain syndrome. J Urol 2005;174:151-154.
48. Stanford E, McMurphy C. There is a low incidence of recurrent bacteriuria in painful bladder syndrome/interstitial cystitis patients followed longitudinally. Int Urogynecol J Pelvic Floor Dysfunct 2007;18:551-554.
49. Eggertsdottir AV, Lund HS, Krontveit R, et al. Bacteriuria in cats with feline lower urinary tract disease: A clinical study of 134 cases in Norway. J Feline Med Surg 2007;9:458-465.
50. Litster A, Thompson M, Moss S, et al. Feline bacterial urinary tract infections: An update on an evolving clinical problem. Vet J 2011;187:18-22.
51. Griffin DW, Gregory CR. Prevalence of bacterial urinary tract infection after perineal urethrostomy in cats. J Am Vet Med Assoc 1992;200:681-684.
52. Nickel JC, Shoskes D, Irvine-Bird K. Clinical phenotyping of women with interstitial cystitis/painful bladder syndrome: A key to classification and potentially improved management. J Urol 2009;182:155-160.
53. Warren JW, Brown V, Jacobs S, et al. Urinary tract infection and inflammation at onset of interstitial cystitis/painful bladder syndrome. Urology 2008;71:1085-1090.
54. Hurst RE, Parsons CL, Roy JB, et al. Urinary glycosaminoglycan excretion as a laboratory marker in the diagnosis of interstitial cystitis. J Urol 1993;149:31-35.
55. Wei DC, Politano VA, Selzer MG, et al. The association of elevated urinary total to sulfated glycosaminoglycan ratio and high molecular mass hyaluronic acid with interstitial cystitis. J Urol 2000;163:1577-1583.
56. Hauser PJ, Dozmorov MG, Bane BL, et al. Abnormal expression of differentiation related proteins and proteoglycan core proteins in the urothelium of patients with interstitial cystitis. J Urol 2008;179:764-769.
57. Pereira DA, Aguiar JAK, Hagiwara MK, et al. Changes in cat urinary glycosaminoglycans with age and in feline urologic syndrome. Biochim Biophys Acta-Gen Subj 2004;1672:1-11.
58. Press SM, Moldwin R, Kushner L, et al. Decreased expression of GP-51 glycosaminoglycan in cats afflicted with feline interstitial cystitis. J Urol 1995;153:288A.
59. Liebert M. The urothelial glycosaminoglycan layer revisited. J Urol 2009;182:2103-2104.
60. Chew DJ, Bartges JW, Adams LG, et al Randomized, placebo-controlled clinical trial of pentosan polysulfate sodium for treatment of feline interstitial (idiopathic) cystitis. In: ACVIM Forum, Montreal, Quebec, JVIM, 2009, 674.
61. Gunn-Moore DA, Shenoy CM. Oral glucosamine and the management of feline idiopathic cystitis. J Feline Med Surg 2004;6:219-225.
62. Holm-Bentzen M, Jacobsen F, Nerstrom B, et al. A prospective double-blind clinically controlled multicenter trial of sodium pentosanpolysulfate in the treatment of interstitial cystitis and related painful bladder disease. J Urol 1987;138:503-507.
63. Dimitrakov J, Kroenke K, Steers WD, et al. Pharmacologic management of painful bladder syndrome/interstitial cystitis: A systematic review. Arch Intern Med 2007;167:1922-1929.
64. Nickel JC, Egerdie RB, Steinhoff G, et al. A multicenter, randomized, double-blind, parallel group pilot evaluation of the efficacy and safety of intravesical sodium chondroitin sulfate versus vehicle control in patients with interstitial cystitis/painful bladder syndrome. Urology 2010;76:804-809.
65. Khandelwal P, Abraham SN, Apodaca G. Cell biology and physiology of the uroepithelium. Am J Physiol Renal Physiol 2009;297:F1477-F1501.
66. Apodaca G. The uroepithelium: Not just a passive barrier. Traffic 2004;5:117-128.
67. Birder LA, Kanai AJ, Cruz F, et al. Is the urothelium intelligent? Neurourol Urodyn 2010;29:598-602.
68. Gao X, Buffington CA, Au JL. Effect of interstitial cystitis on drug absorption from urinary bladder. J Pharmacol Exp Ther 1994;271:818-823.
69. Lavelle JP, Meyers SA, Ruiz WG, et al. Urothelial pathophysiological changes in feline interstitial cystitis: A human model. Am J Physiol Renal Physiol 2000;278:F540-F553.
70. Veranic P, Jezernik K. The response of junctional complexes to induced desquamation in mouse bladder urothelium. Biol Cell 2000;92:105-113.
71. Paus R, Theoharides TC, Arck PC. Neuroimmunoendocrine circuitry of the 'brain-skin connection'. Trends Immunol 2006;27:32-39.
72. Funakoshi K, Nakano M, Atobe Y, et al. Differential development of TRPV1-expressing sensory nerves in peripheral organs. Cell Tissue Res 2006;323:27-41.
73. Birder LA. Urinary bladder urothelium: Molecular sensors of chemical/thermal/mechanical stimuli. Vasc Pharmacol 2006;45:221-226.
74. Birder LA, Wolf-Johnston A, Buffington CA, et al. Altered inducible nitric oxide synthase expression and nitric oxide production in the bladder of cats with feline interstitial cystitis. J Urol 2005;173:625-629.
75. Birder LA, Barrick SR, Roppolo JR, et al. Feline interstitial cystitis results in mechanical hypersensitivity and altered ATP release from bladder urothelium. Am J Physiol-Renal Fluid Electrolyte Physiol 2003;285:F423-F429.
76. Buffington CAT, Chew DJ, Woodworth BE. Animal model of human disease-feline interstitial cystitis. Comp Path Bull 1997;29:3-6.
77. Tomaszewski JE, Landis JR, Russack V, et al. Biopsy features are associated with primary symptoms in interstitial cystitis: results from the interstitial cystitis database study. Urology 2001;57:67-81.
78. Straub RH, Cutolo M. Involvement of the hypothalamic-pituitary-adrenal/gonadal axis and the peripheral nervous system in rheumatoid arthritis: Viewpoint based on a systemic pathogenetic role. Arthritis Rheum 2001;44:493-507.
79. Buffington CAT, Teng BY, Somogyi GT. Norepinephrine content and adrenoceptor function in the bladder of cats with feline interstitial cystitis. J Urol 2002;167:1876-1880.
80. van de Merwe JP, Nordling J, Bouchelouche P, et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: An ESSIC proposal. Eur Urol 2008;53:60-67.
81. Geddy PM, Gray S, Reid WA. Mast-cell density and pgp 9.5-immunostained nerves in angioleiomyoma-their relationship to painful symptoms. Histopathology 1993;22:387-390.
82. Theoharides TC, Cochrane DE. Critical role of mast cells in inflammatory diseases and the effect of acute stress. J Neuroimmunol 2004;146:1-12.
83. Foster HE Jr, Hanno PM, Nickel JC, et al. Effect of amitriptyline on symptoms in treatment naive patients with interstitial cystitis/painful bladder syndrome. J Urol 2010;183:1853-1858.
84. Theoharides TC, Papaliodis D, Tagen M, et al. Chronic fatigue syndrome, mast cells, and tricyclic antidepressants. J Clin Psychopharmacol 2005;25:515-520.
85. Specht A, Kruger JM, Fitzgerald SD, et al. Histochemical and immunohistochemical features of chronic feline idiopathic cystitis. J Vet Intern Med 2004;18:416.
86. Elbadawi A. Interstitial cystitis: A critique of current concepts with a new proposal for pathologic diagnosis and pathogenesis. Urology 1997;49:14-40.
87. Buffington CAT, Chew DJ. Presence of mast cells in submucosa and detrusor of cats with idiopathic lower urinary tract disease. J Vet Intern Med 1993;7:126A.
88. Hannan MT, Felson DT, Pincus T. Analysis of the discordance between radiographic changes and knee pain in osteoarthritis of the knee. J Rheumatol 2000;27:1513-1517.
89. Waxman JA, Sulak PJ, Kuehl TJ. Cystoscopic findings consistent with interstitial cystitis in normal women undergoing tubal ligation. J Urol 1998;160:1663-1667.
90. Levine LA, Richie JP. Urological complications of cyclophosphamide. J Urol 1989;141:1063-1069.
91. Chang L, Munakata J, Mayer EA, et al. Perceptual responses in patients with inflammatory and functional bowel disease. Gut 2000;47:497-505.
92. Chew DJ, Buffington CAT, Kendall MS, et al. Amitriptyline treatment for idiopathic cystitis in cats (15 cases 1994-1996). J Am Vet Med Assoc 1998;213:1282-1286.
93. Thilagarajah R, Witherow RO, Walker MM. Oral cimetidine gives effective symptom relief in painful bladder disease: A prospective, randomized, double-blind placebo-controlled trial. Br J Urol 2001;87:207-212.
94. Peeker R, Aldenborg F, Fall M. The treatment of interstitial cystitis with supratrigonal, cystectomy and ileocystoplasty: Difference in outcome between classic and nonulcer disease. J Urol 1998;159:1479-1482.
95. Roppolo JR, Tai C, Booth AM, et al. Bladder A-delta afferent nerve activity in normal cats and cats with feline interstitial cystitis. J Urol 2005;173:1011-1015.
96. Parsons CL, Greenberger M, Gabal L, et al. The role of urinary potassium in the pathogenesis and diagnosis of interstitial cystitis. J Urol 1998;159:1862-1866.
97. Hohlbrugger G. Leaky urothelium and/or vesical ischemia enable urinary potassium to cause idiopathic urgency/frequency syndrome and urge incontinence. Int Urogynecol J Pelvic Floor Dysfunct 1996;7:242-255.
98. Caito M. The presence and distribution of substance P and neuron-specific enolase in the feline bladder. Columbus, OH: The Ohio State University; 1995. MS Thesis Veterinary Anatomy.
99. Hohenfellner M, Nunes L, Schmidt RA, et al. Interstitial cystitis: Increased sympathetic innervation and related neuropeptide synthesis. J Urol 1992;147:587-591.
100. Peeker R, Aldenborg F, Dahlstrom A, et al. Increased tyrosine hydroxylase immunoreactivity in bladder tissue from patients with classic and nonulcer interstitial cystitis. J Urol 2000;163:1112-1115.
101. Buffington CAT, Wolfe SA High affinity binding sites for [3H]Substance P in urinary bladders of cats with interstitial cystitis. J Urol 1998;160:605-611.
102. Marchand JE, Sant GR, Kream RM. Increased expression of substance P receptor-encoding mRNA in bladder biopsies from patients with interstitial cystitis. Br J Urol 1998;81:224-228.
103. Sanchez Freire V, Burkhard FC, Kessler TM, et al. MicroRNAs may mediate the down-regulation of neurokinin-1 receptor in chronic bladder pain syndrome. Am J Path 2010;176:288-303.
104. Rupniak NMJ, Kramer MS. Discovery of the anti-depressant and anti-emetic efficacy of substance P receptor (NK1) antagonists. Trends Pharmacol Sci 1999;20:485-490.
105. Hill R. Reply: Will changing the testing paradigms show that NK1 receptor antagonists are analgesic in humans? Trends Pharmacol Sci 2000;21:465-465.
106. Sun NN, Wong SS, Keith I, et al. Tachykinin substance P depletion by capsaicin exacerbates inflammatory response to sidestream cigarette smoke in rats. Toxicology 2004;201:39-50.
107. Okajima K, Harada N. Regulation of inflammatory responses by sensory neurons: Molecular mechanism(s) and possible therapeutic applications. Curr Med Chem 2006;13:2241-2251.
108. Sculptoreanu A, deGroat WC, Buffington CAT, et al. Abnormal excitability in capsaicin-responsive DRG neurons from cats with feline interstitial cystitis. Exp Neurol 2005;193:437-443.
109. Wein AJ. Resiniferatoxin in the treatment of interstitial cystitis: A systematic review-editorial comment. J Urol 2009;182:2328-2329.
110. March PA, Buffington CAT. Effects of resiniferatoxin on vesico-sympathetic reflexes and cortical activation in cats with feline interstitial cystitis. Soc Neurosci Abst 2001;27.
111. Payne CK, Mosbaugh PG, Forrest JB, et al. Intravesical resiniferatoxin for the treatment of interstitial cystitis: A randomized, double-blind, placebo controlled trial. J Urol 2005;173:1590-1594.
112. Toft BR, Nordling J. Recent developments of intravesical therapy of painful bladder syndrome/interstitial cystitis: A review. Curr Opin Urol 2006;16:268-272.
113. Caston HT. Stress and the feline urological syndrome. Feline Prac 1973;3:14-22.
114. Kirk H. Retention of urine and urine deposits. In: Kirk H, ed. The Diseases of the Cat and its General Management. London: Bailliere, Tindall and Cox; 1925:261-267.
115. Buffington CAT. External and internal influences on disease risk in cats. J Am Vet Med Assoc 2002;220:994-1002.
116. Cameron ME, Casey RA, Bradshaw JWS, et al. A study of environmental and behavioural factors that may be associated with feline idiopathic cystitis. J Sm Anim Pract 2004;45:144-147.
117. Jones BR, Sanson RL, Morris RS. Elucidating the risk factors of feline urologic syndrome. N Z Vet J 1997;45:100-108.
118. Koziol JA, Clark DC, Gittes RF, et al. The natural history of interstitial cystitis: A survey of 374 patients. J Urol 1993;149:465-469.
119. Rothrock NE, Lutgendorf SK, Kreder KJ, et al. Stress and symptoms in patients with interstitial cystitis: A life stress model. Urology 2001;57:422-427.
120. Reche AJ, Buffington CAT. Increased tyrosine hydroxylase immunoreactivity in the locus coeruleus of cats with interstitial cystitis. J Urol 1998;159:1045-1048.
121. Welk KA, Buffington CAT. Effect of interstitial cystitis on central neuropeptide and receptor immunoreactivity in cats. In: Nyberg L, ed. Research Insights into Interstitial Cystitis. Alexandria, VA: National institute of Diabetes and Digestive and Kidney Diseases; 2003:74.
122. Sands SA, Strong R, Corbitt J, et al. Effects of acute restraint stress on tyrosine hydroxylase mRNA expression in locus coeruleus of Wister and Wistar-Kyoto rats. Mol Brain Res 2000;75:1-7.
123. Chrousos GP, Gold PW. The concepts of stress and stress system disorders. J Am Med Assoc 1992;267:1244-1252.
124. Van Bockstaele EJ, Peoples J, Valentino RJ. A.E. Bennett Research Award. Anatomic basis for differential regulation of the rostrolateral peri-locus coeruleus region by limbic afferents. Biol Psychiatry 1999;46:1352-1363.
125. Buffington CA, Pacak K Increased plasma norepinephrine concentration in cats with interstitial cystitis. J Urol 2001;165:2051-2054.
126. Ullrich PM, Turner JA, Ciol M, et al. Stress is associated with subsequent pain and disability among men with nonbacterial prostatitis/pelvic pain. Ann Behav Med 2005;30:112-118.
127. Whitmore K. Self-care regimens for patients with interstitial cystitis. Urol Clin N Am 1994;21:121-130.
128. McEwen BS. Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators. Eur J Pharmacol 2008;583:174-185.
129. Ursin H, Eriksen HR. The cognitive activation theory of stress. Psychoneuroendocrinology 2004;29:567-592.
130. Broom DM. Animal welfare defined in terms of attempts to cope with the environment. Acta Agric Scand Sect A-Anim Sci 1996;27 (Suppl):22-28.
131. Korte SM, Koolhaas JM, Wingfield JC, et al. The Darwinian concept of stress: Benefits of allostasis and costs of allostatic load and the trade-offs in health and disease. Neurosci Biobehav Rev 2005;29:3-38.
132. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: The role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009;65:732-741.
133. Davis M. Neural systems involved in fear and anxiety measured with fear-potentiated startle. Am Psychol 2006;61:741-756.
134. Buffington CAT. Effect of feline interstitial cystitis on acoustic startle response. Program No. 670.14. 2002 Neuroscience Meeting Planner. Orlando, FL: Society for Neuroscience 2002. Online.
135. Twiss C, Kilpatrick L, Craske M, et al. Increased startle responses in interstitial cystitis: Evidence for central hyperresponsiveness to visceral related threat. J Urol 2009;181:2127-2133.
136. Kilpatrick LA, Ornitz E, Ibrahimovic H, et al. Gating of sensory information differs in patients with interstitial cystitis/painful bladder syndrome. J Urol 2010;184:958-963.
137. Westropp JL, Kass PH, Buffington CAT. In vivo evaluation of the alpha-2 adrenoceptors in cats with idiopathic cystitis. Am J Vet Res 2007;68:203-207.
138. Birder L. Role of the urothelium in bladder function. Scand J Urol Nephrol 2004;215 (Suppl):48-53.
139. Wolf-Johnston AS, Buffington A, Roppolo JR, et al. Consequences of elevated NGF levels in urinary bladder and sensory neurons in feline interstitial cystitis and cyclophosphamide induced cystitis. J Urol 2004;171:96.
140. Jacobs BL, Smaldone MC, Tyagi V, et al. Increased nerve growth factor in neurogenic overactive. Bladder and interstitial cystitis patients. Can J Urol 2010;17:4989-4994.
141. Birder LA, Wolf-Johnston A, Griffiths D, et al. Role of urothelial nerve growth factor in human bladder function. Neurourol Urodyn 2007;26:405-409.
142. Birder LA, Hanna-Mitchell AT, Mayer EA, et al. Cystitis, epithelial dysfunction and co-morbid disorders. Neurourol Urodyn 2011. In press.
143. Fields H. State-dependent opioid control of pain. Nat Rev Neurosci 2004;5:565-575.
144. Schommer NC, Hellhammer DH, Kirschbaum C. Dissociation between reactivity of the hypothalamus-pituitary-adrenal axis and the sympathetic-adrenal-medullary system to repeated psychosocial stress. Psychosom Med 2003;65:450-460.
145. Kvetnansky R, Fukuhara K, Pacak K, et al. Endogenous glucocorticoids restrain catecholamine synthesis and release at rest and during immobilization stress in rats. Endocrinology 1993;133:1411-1419.
146. Westropp JL, Buffington CAT. Effect of a corticotropin releasing factor (crf) antagonist on hypothalamic-pituitary-adrenal activation in response to crf in cats with interstitial cystitis. In: Nyberg L, ed. Research Insights into Interstitial Cystitis. Alexandria, VA: National Institute of Diabetes and Digestive and Kidney Diseases; 2003:73.
147. Heim C, Ehlert U, Hellhammer DH. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology 2000;25:1-35.
148. Lutgendorf SK, Latini JM, Rothrock N, et al. Autonomic response to stress in interstitial cystitis. J Urol 2004;172:227-231.
149. Westropp JL, Buffington CAT. Cerebrospinal fluid corticotrophin releasing factor and catecholamine concentrations in healthy cats and cats with interstitial cystitis. In: Nyberg L, ed. Research Insights into Interstitial Cystitis. Alexandria, VA: National Institute of Diabetes and Digestive and Kidney Diseases; 2003:72.
150. Dimitrakov J, Joffe HV, Soldin SJ, et al. Adrenocortical hormone abnormalities in men with chronic prostatitis/chronic pelvic pain syndrome. Urology 2008;71:261-266.
151. Fries E, Hesse J, Hellhammer J, et al. A new view on hypocortisolism. Psychoneuroendocrinology 2005;30:1010-1016.
152. Buijs RM, Wortel J, Van Heerikhuize JJ, et al. Anatomical and functional demonstration of a multisynaptic suprachiasmatic nucleus adrenal (cortex) pathway. Eur J Neurosci 1999;11:1535-1544.
153. Engeland WC, Arnhold MM. Neural circuitry in the regulation of adrenal corticosterone rhythmicity. Endocrine 2005;28:325-332.
154. Carlstead K, Brown JL, Strawn W. Behavioral and physiological correlates of stress in laboratory cats. Appl Anim Behav Sci 1993;38:143-158.
155. Carlstead K, Shepherdson DS. Alleviating stress in zoos with environmental enrichment. In: Moberg GP, Mench JA, eds. The Biology of Animal Stress: Basic Principles and Implications for Animal Welfare. New York: CABI Publishing; 2000:337-354.
156. Dantzer R, O'Connor JC, Freund GG, et al. From inflammation to sickness and depression: When the immune system subjugates the brain. Nat Rev Neurosci 2008;9:46-56.
157. Marques-Deak A, Cizza G, Sternberg E. Brain-immune interactions and disease susceptibility. Mol Psychiatr 2005;10:239-250.
158. Raison CL, Miller AH. When not enough is too much: The role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am J Psychiatry 2003;160:1554-1565.
159. Strouse TB. The relationship between cytokines and pain/depression: A review and current status. Curr Pain Headache Rep 2007;11:98-103.
160. Bierhaus A, Wolf J, Andrassy M, et al. A mechanism converting psychosocial stress into mononuclear cell activation. Proc Natl Acad Sci U S A 2003;100:1920-1925.
161. Kumar A, Takada Y, Boriek AM, et al. Nuclear factor-kappa B: Its role in health and disease. J Mol Med 2004;82:434-448.
162. Wen Y, Yang SH, Liu R, et al. Estrogen attenuates nuclear factor-kappa B activation induced by transient cerebral ischemia. Brain Res 2004;1008:147-154.
163. Hayashi R, Wada H, Ito K, et al. Effects of glucocorticoids on gene transcription. Eur J Pharmacol 2004;500:51-62.
164. Turrin NP, Rivest S. Unraveling the molecular details involved in the intimate link between the immune and neuroendocrine systems. Exp Biol Med 2004;229:996-1006.
165. Nadeau S, Rivest S. Glucocorticoids play a fundamental role in protecting the brain during innate immune response. J Neurosci 2003;23:5536-5544.
166. Koulich E, Nguyen T, Johnson K, et al. NF-kappa B is involved in the survival of cerebellar granule neurons: Association of I kappa beta phosphorylation with cell survival. J Neurochem 2001;76:1188-1198.
167. Freeman LM, Brown DJ, Smith FW, et al. Magnesium status and the effect of magnesium supplementation in feline hypertrophic cardiomyopathy. Can J Vet Res 1997;61:227-231.
168. Rodriguez MA, Afari N, Buchwald DS. Evidence for overlap between urological and nonurological unexplained clinical conditions. J Urol 2009;182:2123-2131.
169. Peters KM, Carrico DJ, Diokno AC. Characterization of a clinical cohort of 87 women with interstitial cystitis/painful bladder syndrome. Urology 2008;71:634-640.
170. Clemens JQ, Meenan RT, O'Keeffe Rosetti MC, et al. Case-control study of medical comorbidities in women with interstitial cystitis. J Urol 2008;179:2222-2225.
171. McEwen BS, Gianaros PJ. Central role of the brain in stress and adaptation: Links to socioeconomic status, health, and disease. In: Adler NE, Stewart J, eds. Biology of Disadvantage: Socioeconomic Status and Health. Oxford, UK: Blackwell Publishing; 2010:190-222.
172. Gluckman PD, Hanson MA The conceptual basis for the developmental origins of health and disease. In: Gluckman PD, Hanson MA, eds. Developmental Origins of Health and Disease. Cambridge, UK: Cambridge University Press; 2006:33-50.
173. Matthews SG. Early programming of the hypothalamo-pituitary-adrenal axis. Trends Endocrinol Metab 2002;13:373-380.
174. Coplan JD, Smith EL, Altemus M, et al. Variable foraging demand rearing: Sustained elevations in cisternal cerebrospinal fluid corticotropin-releasing factor concentrations in adult primates. Biol Psychiatry 2001;50:200-204.
175. Meaney MJ, Szyf M. Maternal care as a model for experience-dependent chromatin plasticity? Trends Neurosci 2005;28:456-463.
176. Weaver IC, Champagne FA, Brown SE, et al. Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: Altering epigenetic marking later in life. J Neurosci 2005;25:11045-11054.
177. Tsankova NM, Berton O, Renthal W, et al. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 2006;9:519-525.
178. Card JP, Levitt P, Gluhovsky M, et al. Early experience modifies the postnatal assembly of autonomic emotional motor circuits in rats. J Neurosci 2005;25:9102-9111.
179. Holmes A, le Guisquet AM, Vogel E, et al. Early life genetic, epigenetic and environmental factors shaping emotionality in rodents. Neurosci Biobehav Rev 2005;29:1335-1346.
180. Randich A, Uzzell T, DeBerry JJ, et al. Neonatal urinary bladder inflammation produces adult bladder hypersensitivity. J Pain 2006;7:469-479.
181. Al-Chaer ED, Kawasaki M, Pasricha PJ. A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development. Gastroenterology 2000;119:1276-1285.
182. Barreau F, Ferrier L, Fioramonti J, et al. New insights in the etiology and pathophysiology of irritable bowel syndrome: Contribution of neonatal stress models. Pediatr Res 2007;62:240-245.
183. Newport DJ, Heim C, Bonsall R, et al. Pituitary-adrenal responses to standard and low-dose dexamethasone suppression tests in adult survivors of child abuse. Biol Psychiatry 2004;55:10-20.
184. Heim C, Newport DJ, Heit S, et al. Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. J Am Med Assoc 2000;284:592-597.
185. Lackner JM, Gudleski GD, Blanchard EB. Beyond abuse: The association among parenting style, abdominal pain, and somatization in IBS patients. Behav Res Ther 2004;42:41-56.
186. Gunnar M, Quevedo K. The neurobiology of stress and development. Annu Rev Psychol 2007;58:145-173.
187. Heim C, Newport DJ, Wagner D, et al. The role of early adverse experience and adulthood stress in the prediction of neuroendocrine stress reactivity in women: A multiple regression analysis. Depress Anxiety 1999;15:117-125.
188. Oemler M, Grabhorn R, Vahlensieck W, et al. Psychosocial aspects of interstitial cystitis: Do biographical factors have a relevant impact on the disease course? Urologe A 2006;45:728-733.
189. Schmidt MV. Molecular mechanisms of early life stress-Lessons from mouse models. Neurosci Biobehav Rev 2010;34:845-852.
190. Bale TL, Baram TZ, Brown AS, et al. Early life programming and neurodevelopmental disorders. Biol Psychiatry 2010;68:314-319.
191. Korosi A, Shanabrough M, McClelland S, et al. Early-life experience reduces excitation to stress-responsive hypothalamic neurons and reprograms the expression of corticotropin-releasing hormone. J Neurosci 2010;30:703-713.
192. Lupien SJ, McEwen BS, Gunnar MR, et al. Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci 2009;10:434-445.
193. Kirkengen AL, Ulvestad E. Heavy burdens and complex disease-an integrated perspective. J Norwegian Med Assoc 2007;127:3228-3231.
194. Yehuda R, Flory JD, Pratchett LC, et al. Putative biological mechanisms for the association between early life adversity and the subsequent development of PTSD. Psychopharmacology (Berlin) 2010;212:405-417.
195. Cooper ES, Owens TJ, Chew DJ, et al. A protocol for managing urethral obstruction in male cats without urethral catheterization. J Am Vet Med Assoc 2010;237:1261-1266.